Lung metastases at the initial diagnosis of high-grade osteosarcoma
prevalence, risk factors and prognostic factors. A large population-based cohort study
Keywords:
Survival analysis, Osteosarcoma, Neoplasm metastasis, Retrospective studiesAbstract
BACKGROUND: Osteosarcoma is the most prevalent malignant bone tumor in children and adolescents. Lung metastases are associated with poor prognosis. OBJECTIVE: The aim here was to explore the prevalence of and risk and prognostic factors for lung metas-tases in high-grade osteosarcoma patients. DESIGN AND SETTING: Retrospective cohort study based on the Surveillance, Epidemiology and End Results (SEER) database in the United States. METHODS: Data on 1,408 high-grade osteosarcoma patients registered in the SEER database between 2010 and 2015 were extracted. From these, all patients with high-grade osteosarcoma and initial lung metastasis were selected for analysis on risk and prognostic factors for lung metastases. Overall survival was estimated. RESULTS: There were 238 patients (16.90%) with lung metastases at diagnosis. Axial location, tu- mor size > 10 cm (odds ratio, OR 3.19; 95% confidence interval, CI: 1.58-6.45), higher N stage (OR 4.84; 95% CI: 1.94‑12.13) and presence of bone metastases (OR 8.73; 95% CI: 4.37-17.48) or brain metastases (OR 25.63; 95% CI: 1.55-422.86) were significantly associated with lung metastases. Younger age and sur-gical treatment (hazard ratio, HR 0.46; 95% CI: 0.30-0.71) favored survival. Median survival was prolonged through primary tumor surgery. CONCLUSIONS: The factors revealed here may guide lung metastasis screening and prophylactic treat-ment for osteosarcoma patients. A primary tumor in an axial location, greater primary tumor size, higher lymph node stage and presence of bone or brain metastases were significantly correlated with lung me-tastases. The elderly group (≥ 60 years) showed significant correlation with poor overall survival. For im-proved survival among high-grade osteosarcoma patients with lung metastases, aggressive surgery on the primary tumor site should be encouraged.
Downloads
References
ESMO/European Sarcoma Network Working Group. Bone sarcomas:ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol. 2014;Suppl 3:iii113-23. PMID: 25210081; doi: 10.1093/annonc/mdu256.
Zhu Y, Tang L, Zhao S, et al. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613. Cancer Sci. 2018;109(8):2412-22. PMID: 29845707; doi: 10.1111/cas.13653.
Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma:presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol.2003;21(10):2011-8. PMID: 12743156; doi: 10.1200/JCO.2003.08.132.
Meyers PA, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol. 1993;11(3):449- 53. PMID: 8445419; doi: 10.1200/JCO.1993.11.3.449.
Aljubran AH, Griffin A, Pintilie M, Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol. 2009;20(6):1136-41. PMID: 19153114; doi:10.1093/annonc/mdn731.
Kempf-Bielack B, Bielack SS, Jürgens H, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patientsin the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005;23(3):559-68. PMID: 15659502; doi: 10.1200/JCO.2005.04.063.
Estrada-Villaseor E, Escamilla-Uribe R, De la Garza-Montano P, et al. Association of Metastasis with Clinicopathological Data in Mexican Patients with Osteosarcoma, Giant Cell Tumor of Bone and Chondrosarcoma. Asian Pac J Cancer Prev. 2015;16(17):7689-94. PMID: 26625782; doi: 10.7314/APJCP.2015.16.17.7689.
Munajat I, Zulmi W, Norazman MZ, et al. Tumour volume and lung metastasis in patients with osteosarcoma. J Orthop Surg (Hong Kong). 2008;16(2):182-5. PMID: 18725669; doi: 10.1177/230949900801600211.
Wang B, Tu J, Yin J, et al. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma. Oncotarget. 2015;6(35):38348-59. PMID: 26435480; doi: 10.18632/oncotarget.5276.
Brennecke P, Arlt MJ, Muff R, et al. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice. PLoS One. 2013;8(9):e74045. PMID: 24040160; doi: 10.1371/journal.pone.0074045.
Buddingh EP, Anninga JK, Versteegh MI, et al. Prognostic factors in pulmonary metastasized high-grade osteosarcoma. Pediatr Blood Cancer. 2010;54(2):216-21. PMID: 19890902; doi: 10.1002/pbc.22293.
Leary SE, Wozniak AW, Billups CA, et al. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children’s Research Hospital experience. Cancer. 2013;119(14):2645-53. PMID: 23625626; doi: 10.1002/cncr.28111.
Gelderblom H, Jinks RC, Sydes M, et al. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer. 2011;47(6):895-902. PMID: 21216138; doi: 10.1016/j.ejca.2010.11.036.
Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am. 2013;95(13):e89. PMID: 23824394; doi: 10.2106/JBJS.L.01189.
Grimer RJ, Cannon SR, Taminiau AM, et al. Osteosarcoma over the age of forty. Eur J Cancer. 2003;39(2):157-63. PMID: 12509946. doi: 10.1016/s0959-8049(02)00478-1.
Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in highgrade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20(3):776-90. PMID: 11821461; doi: 10.1200/JCO.2002.20.3.776.
Jawad MU, Cheung MC, Clarke J, Koniaris LG, Scully SP. Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol. 2011;137(4):597-607. PMID: 20514491; doi: 10.1007/ s00432-010-0923-7.
Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 2008;134(3):281-97. PMID: 17965883; doi: 10.1007/s00432-007-0330-x.
Guo X, Zhang C, Guo Q, et al. The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Manag Res. 2018;10:1639-46. PMID: 29970963; doi: 10.2147/CMAR.S168579.
